Skip to main content

Senate drops stem cell provision; OA likely to pass

The US Senate dropped language from a bill yesterday that would have directed federal money to research on stem cell lines derived before June 15, 2007, the linkurl:Chronicle of Higher Education;https://chronicle.com/news/article/3262/senate-removes-stem-cell-provision-opposed-by-bush-from-spending-bill reported. The move was made in hopes to avert a presidential veto over the stem cell provision. The language was part of a Senate Appropriations Committee budget measure for 2008, proposed in Jun

Written byAndrea Gawrylewski
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
The US Senate dropped language from a bill yesterday that would have directed federal money to research on stem cell lines derived before June 15, 2007, the linkurl:Chronicle of Higher Education;https://chronicle.com/news/article/3262/senate-removes-stem-cell-provision-opposed-by-bush-from-spending-bill reported. The move was made in hopes to avert a presidential veto over the stem cell provision. The language was part of a Senate Appropriations Committee budget measure for 2008, proposed in June of this year, which would allow research on 400 lines of stem cells derived in private academic and independent laboratories. The $152 billion spending bill also includes provisions for the Departments of Education and Health and Human Services. Word is that the president -- as he has in the linkurl:past;https://www.the-scientist.com/blog/display/53063/ -- may still veto the bill, despite the removal of the stem cell language, because of the high level of spending. "We wanted to show that we are willing to compromise," said Sen. Tom Harkin, democrat from Iowa, in a floor statement. "We're willing to try to meet the president halfway." In response to strident federal restrictions on stem cell research, many linkurl:states;https://www.the-scientist.com/blog/display/53690/ have engineered funding plans of their own; New Jersey voters will vote whether to borrow $450 million for stem cell research on November 6. The bill, if passed, would also require all research funded by the National Institutes of Health to be open access, as we reported in linkurl:July;https://www.the-scientist.com/news/display/53366/,%22 . "The strengthened NIH open access policy in the Appropriations Bill provides a valuable opportunity to enhance access to the results of biomedical research funded by US taxpayers," Matt Cockerill, the publisher of BioMed Central (a sister company of The Scientist) wrote to me in an Email this morning. Funders around the world have recognized the benefits of open access, he added, and "an open access mandate from NIH, the world's largest biomedical funder, is a natural next step."
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo